Assertio Holdings Inc. (NASDAQ: ASRT)
$1.56
-0.1000 ( -6.02% ) 1.7M
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Market Data
Open
$1.56
Previous close
$1.66
Volume
1.7M
Market cap
$146.49M
Day range
$1.54 - $1.73
52 week range
$0.73 - $5.78
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | May 28, 2024 |
4 | Insider transactions | 1 | May 14, 2024 |
4 | Insider transactions | 1 | May 14, 2024 |
4 | Insider transactions | 1 | May 14, 2024 |
8-k | 8K-related | 15 | May 06, 2024 |
10-q | Quarterly Reports | 99 | May 06, 2024 |
def | Proxies and info statements | 6 | Apr 19, 2024 |
ars | Annual reports | 1 | Apr 19, 2024 |
3 | Insider transactions | 2 | Apr 09, 2024 |
pre | Proxies and info statements | 6 | Apr 09, 2024 |